GRIFFIN updates: D-RVd vs RVd in transplant-eligible patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 154 Скачать Далее
DARA+RVd in Pts w/Transplant Eligible Newly Diagnosed Multiple Myeloma after 24 Months Maintenance International Myeloma Foundation 17:02 2 years ago 1 194 Скачать Далее
Post Hoc Analysis of Sustained MRD Negativity (GRIFFIN Trial) in TE NDMM Patients International Myeloma Foundation 4:05 2 years ago 372 Скачать Далее
An update on GRIFFIN: D-RVd in patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 155 Скачать Далее
Updated results of GRIFFIN: D-RVd vs RVd in patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:51 2 years ago 305 Скачать Далее
GRIFFIN Trial Update - DVRd vs VRd in Newly Diagnosed Myeloma | Peter Voorhees, MD | ASH 2021 HealthTree Foundation for Multiple Myeloma 6:07 2 years ago 572 Скачать Далее
GRIFFIN update: depth of response to D-RVd in transplant eligible NDMM VJHemOnc – Video Journal of Hematology & HemOnc 7:22 4 years ago 95 Скачать Далее
GRIFFIN Study: Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone for Multiple Myeloma DocWire 16:06 3 years ago 589 Скачать Далее
GRIFFIN: subgroup analysis of patients with multiple myeloma with high-risk cytogenetics VJHemOnc – Video Journal of Hematology & HemOnc 1:34 2 years ago 284 Скачать Далее
Post hoc analysis of GRIFFIN: D-RVd vs RVd in NDMM VJHemOnc – Video Journal of Hematology & HemOnc 2:07 2 years ago 110 Скачать Далее
Dr. Braunstein on Updated Results of the GRIFFIN Trial in Multiple Myeloma OncLive 1:23 4 years ago 55 Скачать Далее
Dr. Voorhees on Updated Depth of Response in GRIFFIN Trial in Multiple Myeloma OncLive 1:05 4 years ago 81 Скачать Далее
Patient Reported Outcomes Supports Addition of Daratumumab in Multiple Myeloma Treatment CheckRare 3:15 1 year ago 427 Скачать Далее
Are Four-Drug Combinations the Future for Newly Diagnosed Myeloma? Blood Cancers Today 4:12 2 years ago 29 Скачать Далее
Jacob Laubach on Long-Term Results With Daratumumab Plus RVd Blood Cancers Today 5:35 2 years ago 85 Скачать Далее
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learn... Multiple Myeloma Hub 13:25 2 years ago 143 Скачать Далее
Treatment Benefit of Daratumumab for Multiple Myeloma Supported by 3-Year Follow-Up Data CheckRare 4:56 2 years ago 1 540 Скачать Далее
